Synonym: Biphenyl-2-yl-(7-nitrobenzo[1,2,5]oxadiazol-4-yl)amine; N-2-Biphenylyl-7-nitro-2,1,3-benzoxadiazol-4-amine; N-[1,1′-Biphenyl-2-yl]-7-nitro-2,1,3-Benzoxadiazol-4-amine
CAS Number: 413611-93-5
Empirical Formula (Hill Notation): C18H12N4O3
Molecular Weight: 332.31
MDL Number: MFCD00576774
Linear Formula: C18H12N4O3
Product Type: Chemical
This picture is provided solely for illustration purposes, it may have been created or edited with AI. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material.
This image depicts G3798-25MG.
| assay |
≥98% (HPLC) |
| color |
red |
| form |
powder |
| InChI |
1S/C18H12N4O3/c23-22(24)16-11-10-15(17-18(16)21-25-20-17)19-14-9-5-4-8-13(14)12-6-2-1-3-7-12/h1-11,19H |
| InChI key |
KMJPYSQOCBYMCF-UHFFFAOYSA-N |
| Quality Level |
100  |
| SMILES string |
[O-][N+](=O)c1ccc(Nc2ccccc2-c3ccccc3)c4nonc14 |
| solubility |
DMSO: >10 mg/mL |
| storage temp. |
room temp |
| Biochem/physiol Actions: |
10074-G5 is a c-Myc/Max interaction inhibitor. |
| Biochem/physiol Actions: |
10074-G5 is a c-Myc/Max interaction inhibitor. The c-Myc oncoprotein and its partner Max are intrinsically disordered (ID) monomers that undergo coupled folding and binding upon heterodimerization. 10074-G5, similarly to 10058-F4 (#F3680), specifically inhibits this interaction by binding to c-Myc, thus preventing C-Myc specific DNA binding and target genes regulation. 10074-G5 (2.8 microM) is slightly more potent that 10058-F4 (5.2 microM). It was discovered that 10074-G5 binds to a different specific binding site (region) of C-Myc than 10054-F4. Thus, the compound may become desirable for probing different interactions. |
| Packaging: |
5, 25 mg in glass bottle |
| Hazard Codes |
T |
| Risk Statements |
25-36/37/38 |
| Safety Statements |
26-45 |
| RIDADR |
UN 2811 6.1 / PGIII |
| WGK Germany |
WGK 3 |
| Purity |
≥98% (HPLC) |
| Storage Temp. |
room temp |
| UNSPSC |
12352200 |